(Q43963775)
Statements
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems (English)
Victoria M McLeod
Brian D Kelly
Gian Sberna
Mark Williamson